Sun Pharmaceutical Industries Ltd has completed the (Dollar) 3.2 billion acquisition of Ranbaxy Laboratories Ltd on Wednesday. This merger will make Sun Pharma the largest pharmaceutical company in India with a market share of 9.2% and sales of (Dollar) 1.1 billion, as well as the world's fifth largest maker of generic drugs after Teva, Sandoz, Activas and Mylan. Dilip Shanghvi, Sun Pharma managing director, said, "The merger has created a combined entity which has much more managerial ...Saturday, 28 March 2015
Sun Pharma Announces Closure of Merger Deal With Ranbaxy
Sun Pharmaceutical Industries Ltd has completed the (Dollar) 3.2 billion acquisition of Ranbaxy Laboratories Ltd on Wednesday. This merger will make Sun Pharma the largest pharmaceutical company in India with a market share of 9.2% and sales of (Dollar) 1.1 billion, as well as the world's fifth largest maker of generic drugs after Teva, Sandoz, Activas and Mylan. Dilip Shanghvi, Sun Pharma managing director, said, "The merger has created a combined entity which has much more managerial ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment